sleep deprivation. Sleep deprivation is a principal sleep research tool that results in marked physiological challenge, which provides a means to examine sleep homeostatic processes in response to extended wakefulness. A report from our laboratory demonstrated that following recovery sleep from sleep deprivation, brain high-energy phosphates particularly beta-nucleoside triphosphate (beta-NTP) are markedly increased as measured with phosphorus magnetic resonance spectroscopy (MRS). A more recent study examined the effects of sleep deprivation in opiatedependent methadone-maintained (MM) subjects. The study demonstrated increases in brain beta-NTP following recovery sleep. Interestingly, these increases were of a markedly greater magnitude in MM subjects compared to control subjects. A similar study examined sleep deprivation in cocaine-dependent subjects demonstrating that cocaine-dependent subjects exhibit greater increases in brain beta-NTP following recovery sleep when compared to control subjects. The studies suggest that sleep deprivation in both MM subjects and cocaine-dependent subjects is characterized by greater changes in brain ATP levels than control subjects. Greater enhancements in brain ATP following recovery sleep may reflect a greater disruption to or impact of sleep deprivation in drug dependent subjects, whereby sleep restoration processes may be unable to properly regulate brain ATP and maintain brain high-energy equilibrium. These studies support the notion of a greater susceptibility to sleep loss in drug dependent populations. Additional sleep studies in drug abusing populations are needed, particularly those that examine potential differential effects of sleep deprivation.
Numerous reports have documented a high occurrence of sleep difficulties in drug-dependent populations [1, 2, 3] , subsequently prompting sleep researchers to characterize sleep profiles and sleep physiology in drug-abusing populations. For example, poor sleep has been widely reported in cocaineabusing populations, although studies of cocaine dependence have reported conflicting results of both hypo-and hypersomnia [4, 5, 6, 7, 8, 9] , which underscores the difficulty disseminating the pharmacological effects of acute drug usage on sleep from underlying changes in sleep homeostasis and abstinence. Similarly, numerous studies of alcohol, nicotine, marijuana, and opiate dependence have reported findings of poor sleep and insomnia, particularly during early abstinence [5, 10, 11, 12, 13, 14, 15, 16, 17, 18] . Drugdependent individuals actively in treatment for dependence also report various sleep difficulties. For example, sleep difficulties and insomnia particularly afflict individuals in methadone treatment [19, 20, 21, 22, 23, 24] . Further investigation of sleep disturbances in drug-abusing populations is needed in order to gain understanding of how sleep-altered processes influence behavioral and cognitive performance, as well as potentially contributing to the perpetuation of drug-taking behaviors.
Sleep deprivation is a principal sleep research tool that results in marked behavioral challenges as evidenced by increased daytime sleepiness and task-specific changes in behavioral and cognitive performance [25, 26, 39, 40] . Although sleep deprivation does not always result in impaired or altered performance, functional magnetic resonance imaging studies have identified performance-related changes in regional brain activation indicative of compensatory recruitment of functional brain regions [41, 42, 43] . Studies have also begun to characterize a direct role of multiple neurotransmitter systems in the regulation of sleep [32, 33, 34] . For example, animal studies have demonstrated increases in serotonergic activity in response to sleep deprivation in brain areas such as the dorsal raphe, hippocampus, and frontal cortex [35, 36, 37] . Additionally, these noted enhancements of serotonergic activity have been associated with the antidepressant responses associated with sleep deprivation reported in humans [35, 36, 37, 38] .
The resultant behavioral and physiological challenge of sleep deprivation provides a means of examining sleep homeostatic processes in response to extended wakefulness. The wakefulness presumably results in an extended period of cerebral metabolic activity and demand, allowing the examination of recovery sleep following sleep deprivation [27] . Recent research has begun to identify brain mechanisms associated with the prolonged metabolic activity of sleep deprivation as well as the enhanced restorative quality of recovery sleep [3, 28, 29, 30, 31] . Hence, the study of recovery sleep provides insight into mechanisms potentially involved in the restorative qualities of sleep. Previous magnetic resonance spectroscopy (MRS) imaging studies have examined brain markers of neurochemical abnormalities, neuronal integrity, and metabolic alterations in drug-abusing or -dependent populations [44, 45, 46, 47, 48] . For instance, studies have used phosphorus ( 31 P) MRS brain imaging to examine cerebral high-energy phosphate and phospholipid metabolite changes that result from long-term drug abuse and/or withdrawal in substance abusers [49, 50, 51] . The technique of 31 P MRS imaging allows the direct measurement of brain high-energy phosphates such as alpha-, beta-, and gamma-nucleoside triphosphate (NTP) [52] . While both cytidine and guanosine triphosphates are present in the NTP resonance, the NTP resonance is derived primarily of adenosine triphosphate (ATP) and is at relatively higher concentrations (∼1.8 mM) in the brain [53] . Beta-NTP may be of primary interest as beta-NTP is unique to NTP, whereas alpha-and gamma-NTP also contribute to nucleoside diphosphates (NDP). 31 P MRS imaging provides a direct measure of NTP levels and of the currently available methods for the assessment of in vivo brain adenosine metabolites, 31 P MRS imaging is the most commonly used [54] . A report from our laboratory previously examined how brain ATP levels fluctuate over the course of a total sleep deprivation paradigm in healthy subjects [55] . Specifically, this study demonstrated that following recovery sleep from sleep deprivation, brain high-energy phosphates, particularly beta-NTP, are markedly increased. The increase in ATP following recovery sleep may indicate a sleep homeostatic process by which the restorative processes of recovery sleep require utilization of brain ATP with the prolonged metabolic demands necessary to sustain wake-time function during sleep deprivation. These findings are consistent with animal studies indicating a reduction or depletion of brain glycogen stores [29, 56, 57] . Typically, the oxidation of glycogen is critical to the synthesis of ATP, which is utilized in response to metabolic demands. The neuronal utilization of brain ATP results in ATP metabolism and the by-products adenosine diphosphate (ADP) and inorganic phosphate [58, 59] . Animal studies have provided strong evidence that sleep deprivation results in a build up of brain adenosine [29, 42, 60] , which is associated with enhanced sleep pressure that results in an increased drive to sleep. Similarly, a reduction of brain glycogen stores [56] , as well as a potential interaction with glucocorticoids [57] , have also been demonstrated in response to sleep deprivation. Findings of brain energy changes after recovery sleep support theories that wake-time activity is sustained by brain bioenergetic restorative sleep [29, 61] . Two more recent studies from our laboratory have begun to identify and characterize how drugdependent populations respond to the prolonged wakefulness of total sleep deprivation, measuring both sleep physiology with polysomnography and in vivo measurements of brain high-energy phosphates with 31 P MRS imaging [62, 63] . One study examined the response to sleep deprivation in opiate-dependent
methadone-maintained (MM) subjects. Similar to the findings in control subjects, results indicated that MM subjects exhibited the greatest changes in brain ATP in the morning following recovery sleep (Fig.  1) . Interestingly, MRS imaging data revealed that the enhancements in global brain beta-NTP levels over the course of the sleep deprivation paradigm were of a markedly greater magnitude in MM subjects compared to control subjects. A second study examined the effects of sleep deprivation in cocainedependent subjects. Most notably, cocaine-dependent subjects, similar to MM subjects, exhibited markedly greater enhancements of brain beta-NTP following recovery sleep when compared to control subjects. These preliminary data suggest that sleep deprivation in both MM subjects and cocainedependent subjects is characterized by underlying changes in brain ATP levels involved in sleep homeostasis and sleep restoration. These brain MRS imaging data examining brain bioenergetics support the notion of a greater susceptibility to sleep loss in drug-dependent populations, marked by alterations in sleep homeostatic and restorative processes. Greater enhancements in brain ATP following recovery sleep may reflect a greater disruption to or impact of sleep deprivation in drug-dependent subjects, whereby sleep-restoration processes may be unable to regulate brain ATP properly and maintain brain high-energy equilibrium. A greater susceptibility to sleep deprivation may have profound functional consequences in cognitive and behavioral performance related to shift workers. Hence, additional sleep studies in drug-abusing populations are needed, particularly those that examine potential differential effects of sleep deprivation or sleep restriction. Additionally, insomnia has been associated with the occurrence of psychiatric disorders, depression, and a decline in executive function [64, 65, 66, 67] , and may have a relationship as well to decision making and the continuation of drug-taking behaviors. Greater susceptibility to sleep deprivation is also critical to the understanding of sleep processes in drug-dependent individuals in active treatment such as MM and how persistent drug abuse-related insomnia may increase relapse potential [24] . Elucidating the effects of methadone early in treatment and through the duration of therapy may be useful in extracting factors leading to failed treatment and relapse. These studies highlight the importance of developing novel clinical drug-abuse treatment approaches involving detailed monitoring and regulation of sleep behavior potentially with sleep pharmacotherapy.
